Free Trial

Phathom Pharmaceuticals (PHAT) News Today

$10.73
-0.16 (-1.47%)
(As of 05/21/2024 ET)
Phathom Pharmaceuticals (NASDAQ:PHAT) Receives Buy Rating from Needham & Company LLC
Needham & Company LLC reissued a "buy" rating and set a $26.00 price target on shares of Phathom Pharmaceuticals in a research report on Friday.
Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Up 8.7%
Phathom Pharmaceuticals (NASDAQ:PHAT) Trading 8.7% Higher
The 3 Best Healthcare Stocks to Buy in May 2024
Phathom Pharmaceuticals (NASDAQ:PHAT) Rating Reiterated by Needham & Company LLC
Needham & Company LLC reissued a "buy" rating and set a $26.00 price target on shares of Phathom Pharmaceuticals in a research report on Thursday.
Phathom Pharmaceuticals (NASDAQ:PHAT) Trading Down 5.9%
Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Down 5.9%
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Up 11.8%
Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Up 11.8%
Phathom Pharmaceuticals (NASDAQ:PHAT) Earns Buy Rating from Analysts at Stifel Nicolaus
Stifel Nicolaus began coverage on Phathom Pharmaceuticals in a research note on Friday. They set a "buy" rating and a $24.00 target price for the company.
Needham Keeps Their Hold Rating on Lexicon Pharmaceuticals (LXRX)
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 3.7%
Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Down 3.7%
12 Most Shorted Stocks in 2024
Vanguard Group Inc. Has $19.94 Million Holdings in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT)
Vanguard Group Inc. increased its position in shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT - Free Report) by 10.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,922,662 shares of the company's stock
Phathom Pharmaceuticals (NASDAQ:PHAT) Trading Down 6.2% After Insider Selling
Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Down 6.2% After Insider Selling
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Up 5.5%
Phathom Pharmaceuticals (NASDAQ:PHAT) Trading Up 5.5%
Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Down 8.1%
Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Down 8.1%
Terrie Curran Sells 16,851 Shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Stock
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT - Get Free Report) insider Terrie Curran sold 16,851 shares of the firm's stock in a transaction on Friday, March 22nd. The shares were sold at an average price of $9.11, for a total transaction of $153,512.61. Following the completion of the transaction, the insider now directly owns 410,784 shares of the company's stock, valued at $3,742,242.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Up 5.6%
Phathom Pharmaceuticals (NASDAQ:PHAT) Trading 5.6% Higher
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 4.5%
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 4.5%
SIGA Names Larry Miller General Counsel
Phathom Pharmaceuticals' (PHAT) "Buy" Rating Reaffirmed at Needham & Company LLC
Needham & Company LLC reiterated a "buy" rating and set a $26.00 target price on shares of Phathom Pharmaceuticals in a research report on Friday.
Get Phathom Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for PHAT and its competitors with MarketBeat's FREE daily newsletter.

Exposed: 10 CENT Crypto to Explode May 20th? (Ad)

Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…

Click For My #1 FREE Crypto for 2024

PHAT Media Mentions By Week

PHAT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PHAT
News Sentiment

0.37

0.43

Average
Medical
News Sentiment

PHAT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PHAT Articles
This Week

4

3

PHAT Articles
Average Week

Get Phathom Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for PHAT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:PHAT) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners